SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the March 2026 quarter moved up 41.86% to Rs. 3872.90 millions as compared to Rs. 2730.10 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2026 of Rs. 97.30 millions grew from Rs.-48.80 millionsOP of the company witnessed a marginal growth to 619.70 millions from 485.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 3872.90 2730.10 41.86 13689.80 12837.60 6.64 13689.80 12837.60 6.64
Other Income 44.20 59.50 -25.71 58.90 91.40 -35.56 58.90 91.40 -35.56
PBIDT 619.70 485.40 27.67 1925.70 2129.80 -9.58 1925.70 2129.80 -9.58
Interest 270.60 291.20 -7.07 942.40 1148.10 -17.92 942.40 1148.10 -17.92
PBDT 357.70 194.20 84.19 924.40 981.70 -5.84 924.40 981.70 -5.84
Depreciation 260.40 243.00 7.16 996.80 992.50 0.43 996.80 992.50 0.43
PBT 97.30 -48.80 -299.39 -72.40 -10.80 570.37 -72.40 -10.80 570.37
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 97.30 -48.80 -299.39 -72.40 -10.80 570.37 -72.40 -10.80 570.37
Equity 445.10 402.50 10.58 445.10 402.50 10.58 445.10 402.50 10.58
PBIDTM(%) 16.00 17.78 -10.00 14.07 16.59 -15.21 14.07 16.59 -15.21

Solara Active Pharma Share Price

600.25 27.70 (4.84%)
11-Jun-2026 11:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1791.70
Dr. Reddys Lab 1277.00
Cipla 1383.30
Zydus Lifesciences 1104.85
Lupin 2256.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×